Efficacy of methylprednisolone in children with severe community acquired pneumonia
- 15 May 2012
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 48 (2), 168-175
- https://doi.org/10.1002/ppul.22574
Abstract
Background The clinical value of adjuvant corticosteroid treatment in community‐acquired pneumonia (CAP) seemed to be controversial in adults, and even less data are available on the use of corticosteroids in children with CAP. Materials and Methods In this study, we investigated the efficacy of a 5‐day adjuvant methylprednisolone therapy to imipenem in 29 children with severe CAP. In parallel, 30 subjects with the same disease were treated with imipenem and placebo, and the two study groups were compared based on the different parameters of the primary and secondary end points. The primary end points were the duration of fever, the levels of white blood cells (WBC) and high sensitive C‐reactive protein (hsCRP). Secondary end points were the length of hospital stay, and the number of severe complications with or without surgical interventions. Results The additive methylprednisolone treatment significantly reduced the duration of fever with 2.5 days, the WBC counts (P = 0.014), the hsCRP levels showing a 48.7% decrease, and the length of hospital stay with 5.2 days versus the placebo group. Moreover, patients treated on imipenem alone had twice more complications and four times more invasive interventions compared to those on the combined therapy. Conclusions The 5‐day methylprednisolone therapy with imipenem was found effective in children having severe CAP. However, trials with larger cohorts are needed to study further beneficial effects of corticosteroids in children with CAP. Pediatr Pulmonol. 2013; 48:168–175.Keywords
This publication has 42 references indexed in Scilit:
- Adjunct Corticosteroids in Children Hospitalized With Community-Acquired PneumoniaPEDIATRICS, 2011
- Bacteraemic Pneumococcal PneumoniaDrugs, 2011
- Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC=4 μg ml−1)Journal of Medical Microbiology, 2009
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injuryEuropean Respiratory Journal, 2008
- Effects of glucocorticoids in ventilated piglets with severe pneumoniaEuropean Respiratory Journal, 2008
- The role of corticosteroids in severe community-acquired pneumonia: a systematic reviewCritical Care, 2008
- Sepsis severity predicts outcome in community-acquired pneumococcal pneumoniaEuropean Respiratory Journal, 2007
- Management of Community-Acquired Pneumonia in ChildrenPediatric Drugs, 2007
- Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: Two case reportsScandinavian Journal of Infectious Diseases, 2006